Tuberculosis patients danced in the corridors of New York City’s Sea View Hospital ten years ago to celebrate their speeding recovery on new drugs, mainly isoniazid, or INH (for isonicotinic acid ...

A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George's, University of ...

A new article published in Nature offers a promising path toward a shorter, more effective treatment for tuberculosis (TB), a bacterial disease that affects millions worldwide. Subscribe to our ...

Tuberculosis (TB) is the world's biggest infectious disease killer with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study shows that resistance to the new MDR-TB ...

Tuberculosis, dread disease, drew concentrated attention from doctors, public health workers, social hygienists and Red Cross contributors during the past fortnight. Last week the National ...

The price of pretomanid, a key component used in the treatment of drug-resistant tuberculosis (TB), dropped by 25% in April, to less than $1 per day, primarily owing to Indian manufacturers joining in ...